Literature DB >> 18707003

Pituitary adenylate cyclase-activating polypeptide stimulates glial fibrillary acidic protein gene expression in cortical precursor cells by activating Ras and Rap1.

Isabel Lastres-Becker1, Antonio Fernández-Pérez, Beatriz Cebolla, Mario Vallejo.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) acts on cortical precursor cells to trigger glial fibrillary acidic protein (GFAP) gene expression and astrocyte differentiation by stimulation of intracellular cAMP production. Here, we show that as expected, PACAP activates cAMP-dependent protein kinase A. However, inhibition of protein kinase A does not prevent PACAP-induced GFAP gene expression or astrocytogenesis. PACAP also activates the small GTPases Rap1 and Ras, but either activation of Rap1 alone by selective stimulation of the guanine nucleotide exchange factor Epac, or expression of a constitutively active form of Ras, do not induce GFAP gene expression. Ras is activated by PACAP in a cAMP-dependent manner, and inhibition of Ras and/or Rap1 decreases PACAP-induced GFAP promoter stimulation. Thus, cAMP-dependent PACAP-induced GFAP expression during astrocytogenesis involves the coordinated activation of both Ras and Rap1, but activation of either one of them in isolation is not sufficient to trigger this response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707003     DOI: 10.1016/j.mcn.2008.07.009

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  7 in total

Review 1.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 2.  PACAP signaling to DREAM: a cAMP-dependent pathway that regulates cortical astrogliogenesis.

Authors:  Mario Vallejo
Journal:  Mol Neurobiol       Date:  2009-02-24       Impact factor: 5.590

3.  Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders.

Authors:  Jose A Morales-Garcia; Valle Palomo; Miriam Redondo; Sandra Alonso-Gil; Carmen Gil; Ana Martinez; Ana Perez-Castillo
Journal:  ACS Chem Neurosci       Date:  2014-01-17       Impact factor: 4.418

4.  Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease.

Authors:  Jose A Morales-Garcia; Miriam Redondo; Sandra Alonso-Gil; Carmen Gil; Concepción Perez; Ana Martinez; Angel Santos; Ana Perez-Castillo
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

5.  Cyclic AMP signaling restricts activation and promotes maturation and antioxidant defenses in astrocytes.

Authors:  Sonia Paco; Manuela Hummel; Virginia Plá; Lauro Sumoy; Fernando Aguado
Journal:  BMC Genomics       Date:  2016-04-23       Impact factor: 3.969

6.  CAV-1 Overexpression Exacerbates the Manifestation in EPAC-1-Induced Chronic Postsurgical Pain in Rats.

Authors:  Qian Hua; Shiren Shen; Yibin Qin; Su Cao
Journal:  Pain Res Manag       Date:  2022-07-31       Impact factor: 2.667

7.  Ataxin-2 modulates the levels of Grb2 and SRC but not ras signaling.

Authors:  Jessica Drost; David Nonis; Florian Eich; Oliver Leske; Ewa Damrath; Ewout R Brunt; Isabel Lastres-Becker; Rolf Heumann; Joachim Nowock; Georg Auburger
Journal:  J Mol Neurosci       Date:  2013-01-19       Impact factor: 3.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.